↓ Skip to main content

Lentiviral gene therapy for X-linked chronic granulomatous disease

Overview of attention for article published in Nature Medicine, January 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news
25 news outlets
blogs
4 blogs
twitter
49 X users
patent
1 patent
facebook
6 Facebook pages

Citations

dimensions_citation
180 Dimensions

Readers on

mendeley
227 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Lentiviral gene therapy for X-linked chronic granulomatous disease
Published in
Nature Medicine, January 2020
DOI 10.1038/s41591-019-0735-5
Pubmed ID
Authors

Donald B. Kohn, Claire Booth, Elizabeth M. Kang, Sung-Yun Pai, Kit L. Shaw, Giorgia Santilli, Myriam Armant, Karen F. Buckland, Uimook Choi, Suk See De Ravin, Morna J. Dorsey, Caroline Y. Kuo, Diego Leon-Rico, Christine Rivat, Natalia Izotova, Kimberly Gilmour, Katie Snell, Jinhua Xu-Bayford Dip, Jinan Darwish, Emma C. Morris, Dayna Terrazas, Leo D. Wang, Christopher A. Bauser, Tobias Paprotka, Douglas B. Kuhns, John Gregg, Hayley E. Raymond, John K. Everett, Geraldine Honnet, Luca Biasco, Peter E. Newburger, Frederic D. Bushman, Manuel Grez, H. Bobby Gaspar, David A. Williams, Harry L. Malech, Anne Galy, Adrian J. Thrasher

X Demographics

X Demographics

The data shown below were collected from the profiles of 49 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 227 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 227 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 32 14%
Researcher 31 14%
Student > Bachelor 24 11%
Student > Master 16 7%
Student > Doctoral Student 15 7%
Other 42 19%
Unknown 67 30%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 53 23%
Medicine and Dentistry 39 17%
Immunology and Microbiology 14 6%
Agricultural and Biological Sciences 11 5%
Neuroscience 7 3%
Other 31 14%
Unknown 72 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 224. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 April 2022.
All research outputs
#167,631
of 25,081,285 outputs
Outputs from Nature Medicine
#704
of 9,163 outputs
Outputs of similar age
#4,060
of 464,705 outputs
Outputs of similar age from Nature Medicine
#19
of 111 outputs
Altmetric has tracked 25,081,285 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,163 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 104.3. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 464,705 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 111 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.